华控康泰2025 年报

(Stock Code: 1312)(Incorporated in the Cayman Islands with limited liability) 2025ANNUAL REPORT 目錄CONTENTS 157Consolidated Statement of Profit or Loss andOther Comprehensive Income 5Chairman’s Statement 159Consolidated Statement of Financial Position 8Management Discussion and Analysis 162Consolidated Statement of Changes in Equity 17Environmental, Social and Governance Report 163Consolidated Statement of Cash Flows 97Corporate Governance Report 165Notes to the Consolidated Financial Statements 127Directors’ Report 312Financial Summary 149Independent Auditor’s Report CORPORATE INFORMATION As at the date of this report BOARD OF DIRECTORS Executive Directors Wang Feifei,Chairman and PresidentGuo Zixiu,Financial ControllerLiu Jiankun Independent Non-Executive Directors Tang Lai WahHo Ho MingYao Xiaomin EXECUTIVE COMMITTEE Wang Feifei,ChairmanGuo ZixiuLiu Jiankun AUDIT COMMITTEE Tang Lai Wah,ChairmanHo Ho MingYao Xiaomin REMUNERATION COMMITTEE Yao Xiaomin,ChairmanTang Lai WahHo Ho Ming NOMINATION COMMITTEE Wang Feifei,ChairmanTang Lai WahYao Xiaomin RISKS MANAGEMENT COMMITTEE Ho Ho Ming,ChairmanGuo ZixiuTang Lai Wah SHARE DEALING COMMITTEE Wang Feifei,ChairmanGuo ZixiuLiu Jiankun INVESTMENT COMMITTEE Wang Feifei,ChairmanTang Lai WahHo Ho Ming PRINCIPAL BANKERS Hong Kong Fubon Bank (Hong Kong) LimitedBank of China (Hong Kong) LimitedThe Hongkong and Shanghai Banking Corporation Limited Mainland China Bank of Beijing Co., Ltd.China Construction Bank CorporationPing An Bank Co., Ltd.Bank of China Limited Singapore United Overseas Bank Limited REGISTERED OFFICE Windward 3Regatta Office ParkP.O. Box 1350Grand Cayman KY1-1108Cayman Islands Windward 3Regatta Office ParkP.O. Box 1350Grand Cayman KY1-1108Cayman Islands CORPORATE INFORMATION HEAD OFFICE AND PRINCIPAL PLACE OFBUSINESS 3012A12A1512A202731650027316599info@kontafarma.com.hk Rooms 12A15–12A20, 12A/F, Sun Hung Kai Centre30 Harbour Road, Wanchai, Hong KongTel.:2731 6500Fax:2731 6599E-mail:info@kontafarma.com.hk PRINCIPAL SHARE REGISTRAR Ocorian Trust (Cayman) LimitedWindward 3Regatta Office ParkP.O. Box 1350Grand Cayman KY1-1108Cayman Islands Ocorian Trust (Cayman) LimitedWindward 3Regatta Office ParkP.O. Box 1350Grand Cayman KY1-1108Cayman Islands BRANCH SHARE REGISTRAR IN HONG KONG 1617 Tricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong COMPANY SECRETARY Chan Lok Tung AUTHORISED REPRESENTATIVES Guo ZixiuChan Lok Tung INDEPENDENT AUDITOR BDO Limited SOLICITORS CFN Lawyers LLPWellington Legal LLP STOCK CODE 1312 1312 WEBSITE http://www.kontafarma.com.hk http://www.kontafarma.com.hk On behalf of the board (the “Board”) of directors (the “Directors”)ofKontafarma China Holdings Limited(the“Company”),I ampleasedto present to you the audited annual results of theCompany and its subsidiaries (collectively, the “Group”) for the yearended 31 December 2025. RESULTS 914.7897.51.9%482.699.07.671.35 The revenue of the Group for the year ended 31 December 2025was approximately HK$914.7 million (2024: approximately HK$897.5million),representing an increase of approximately 1.9%ascompared to the previous year. The loss for the year of the Groupwas approximately HK$482.6 million (2024: approximately HK$99.0million).The basic loss per share amounted to approximatelyHK$7.67 cents (2024: approximately HK$1.35 cents). DIVIDEND The Board has resolved not to recommend any final dividend for theyear ended 31 December 2025 (2024: Nil). Dividend Policy The Company has adopted a dividend policy in December 2018. TheCompanyconsiders stable and sustainable returns to theshareholders of the Company (the “Shareholders”) to be its goalandendeavours to maintain the dividend policy to achieve suchgoal. In deciding whether to propose a dividend and in determining thedividend amount, the Board would take into account the Group’sresultsof operations,earnings performance,cashflows,financialcondition,future prospects,as well as statutory and regulatoryrestrictions on the payment of dividends, and other factors that theBoard may consider relevant. Whilst the Board will review from time to time for determination onproposed dividend with the above factors taken into account, therecan be no assurance that dividends will be declared or paid in anyparticular amount for any given period. CHAIRMAN’S STATEMENT Corporate Culture and Visions Adhering to the people-oriented philosophy, the Group extensivelyrecruitstalents from different fields,treasures our staff as ourcornerstone, insists on unity within the Group and values internalcare and communication. By actively putting the subjective initiativeof our staff into play with care and soul, the Group continuouslyenhancesteam cohesion and realizes complementary advantagesand sincere cooperation. During the new era of development, the Group will focus on thetarget of universal health. On one hand, we look forward to thenationaldeployment on u